| Name | Title | Contact Details |
|---|
Intelligent Implants is a medical device company operating at the intersection of digital medicine and orthopedics. We develop innovative electrotherapeutic orthopedic devices to address significant unmet clinical needs. The company`s SmartFuse® platform is a wirelessly enabled, active implant technology that uses an array of electrodes to stimulate, control, and monitor bone growth. Our mission is to leverage SmartFuse to develop a pipeline of smart orthopedic implants that can reduce healing times, engage patients & surgeons, enable digital surgery/robotics and ultimately improve outcomes for millions of patients.
Sonendo, Inc. is a privately held, venture-backed company developing innovative technologies to transform endodontic therapy. Sonendo`s Multisonic Ultracleaning technology addresses the challenges that currently exist in endodontic treatment, offering a solution to the problems that exist within traditional root canal therapy.
Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.
With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.
Manhattan Diagnostic Radiology is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.